A detailed history of Blueshift Asset Management, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Blueshift Asset Management, LLC holds 4,343 shares of TMDX stock, worth $278,907. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,343
Previous 3,806 14.11%
Holding current value
$278,907
Previous $573,000 18.85%
% of portfolio
0.17%
Previous 0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$135.68 - $176.11 $72,860 - $94,571
537 Added 14.11%
4,343 $681,000
Q2 2024

Aug 13, 2024

BUY
$72.62 - $150.62 $276,391 - $573,259
3,806 New
3,806 $573,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.04B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.